The Tesla boss is doing all he can to help the fight against the novel Coronavirus as the company plans to deliver another set of ventilators as humanly possible after initially offering about 1,255 free ventilators.
Musk made it known that the New York factory will restart the process of making more ventilators which will then be sent over to ICUs to help patients who are having difficulty breathing naturally due to the dire situation of the disease on their lungs.
“Giga New York will reopen for ventilator production as soon as humanly possible. We will do anything in our power to help the citizens of New York,” he tweeted on Wednesday.
Making good progress. We will do whatever is needed to help in these difficult times.
- Advertisement -
— Elon Musk (@elonmusk) March 25, 2020
The comment came right after a follower tweeted a video of Medtronic CEO, Omar Ishrak who told the CNBC about Tesla making of the medical device company’s ventilators at it’s Fremont factory in California.
According to researches and official reports from the WHO and CDC, the Coronavirus causes respiratory illness known as the COVID-19 which was thought to have mutated from animal to human and discovered later on last year, December 2019 which had caused a global pandemic since then leading to numerous fatal cases as well as economic slowdown.
As of today based on the Heatmap from Bing, the number of global cases is about 529,614 with a total of 121,454 cases of recovery and 23,714 fatal cases worldwide and the number keeps growing worldwide.
During this time, ventilators are super essential which are used to treat the illness. With numerous cases in the New York, the governor of the state, Andrew Cuomo made it known on Wednesday that the city needs as high as 30,000 ventilators but got only 400 from the Federal Emergency Management Agency.
So Tesla is also joining the fight by providing all it can to help save lives of those that were diagnosed with the disease when in critical situations. Tesla didn’t immediately respond to a request for further comment.